Aciclovir Intravenous (Pfizer (Perth))

What it is used for

OTHER CONDITIONS: Remaining ampoules must be used within 9 months after the foil sachet is opened. Aciclovir Intravenous Injection is indicated for the purposes of: 1. Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus in immunocompromised patients. 2. Treatment of severe first episode primary or non-primary genital herpes in immune competent patients. 3. Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients. 4. Treatment of Herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients. 5. Treatment of Herpes simplex encephalitis. INDICATIONS AS OF 4 NOVEMBER 2002: Aciclovir Intravenous Infusion is indicated for the purpose of: 1. Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immunocompromised patients. 2. Treatment of severe first episode primary or non-primary genital herpes in immunocompetent patients. 3. Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients. 4. Treatment of Herpes zoster (shingles) in immunocompetent patients who show very severe acute local or systemic manifestations of the disease. Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immunocompetent patients with shingles. 5. Treatment of Herpes simplex encephalitis.